US 10836827
Antibodies specific to glycosylated PD-L1 and methods of use thereof
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 10836827 (Antibodies specific to glycosylated PD-L1 and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K45/06